Physician
Pathology
Dr. Harvey J. Alter, MD
|
|
Give Review
Doctor Harvey J. Alter, MD practices Pathology. He studied medicine at University of Rochester School of Medicine and Dentistry. He over the years received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Doctor Harvey J. Alter, MD is a published doctor and has 57 publications published. The lastest was: 'Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.'
Publications
- An Epidemiologic Investigation of a Case of Acute Hepatitis E.
- HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice.
- Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization.
- Differential Responses of Plasmacytoid Dendritic Cells to Influenza and Distinct Viral Pathogens.
- Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors.
- Corrigendum to "The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells" [Virology 438 (201...
- HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion.
- Blood system changes since recognition of transfusion-associated AIDS.
- An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 pro...
- Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response.
- Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus.
- The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells.
- Investigation of residual hepatitis C virus in presumed recovered subjects.
- To Have B or Not to Have B: Vaccine and the Potential Eradication of Hepatitis B.
- Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components.
- Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors.
- Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.
- Understanding the natural history of chronic HBV and HCV infections.
- Genomic scale analysis of racial impact on response to IFN-alpha.
- Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.
- Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.
- The hazards of blood transfusion in historical perspective.
- Pathogen reduction: a precautionary principle paradigm.
- Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
- Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma.
- A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation.
- The epidemiology of transfusion-associated hepatitis C in a children's hospital.
- Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.
- A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.
- Emerging infectious diseases that threaten the blood supply.
- Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees.
- Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively.
- Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.
- Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleot...
- Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C.
- Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
- Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration.
- SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.
- Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection.
- Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light.
- Hepatology highlights.
- PCR-probe capture hybridization assay and statistical model for SEN virus prevalence estimation.
- Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.
- Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis.
- Prevalence of SEN viruses among injection drug users in the San Francisco Bay area.
- Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.
- Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.
- Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.
- Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization.
- Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will incr...
- Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia.
- SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
- Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.
- A neutralization epitope in the hepatitis C virus e2 glycoprotein interacts with host entry factor CD81.
- Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.
Schools
University Of Rochester
Strong Memorial Hospital
University Hospital
Georgetown University
Doctors Specialties
- Blood Banking
- Pathology
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Georgetown University Hospital -
University of Washington -
University of Rochester -
University of Rochester School of Medicine and Dentistry
Helpful Reviews
Similar Doctors
|
|
Dr. Daniel H. Russell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elliott Kagan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paulito A. Fontelo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary E. Goolsby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney D. Boyum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frances I. Manosca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan F. Leitman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Harvey G. Klein, MD |
|
|
Dr. Armin G. Jegalian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elaine S. Jaffe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Leakan, MD |
|
|
Dr. Elaine M. Sloand, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kaihui Liang, MD |